Adrenal insufficiency masquerading as sepsis in a patient with tetraparesis: A case report

Archives of Physical Medicine and Rehabilitation

Volumn 81, Issue 6, 2000, Pages 830-833

  Lee, Laura W ^a   Glenn, Mel B ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adrenal gland hypofunction; Rehabilitation; Spinal cord injuries; Tetraplegia

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; MEGESTROL ACETATE;

ADRENAL INSUFFICIENCY; ADULT; ARTICLE; CACHEXIA; CASE REPORT; CLINICAL EXAMINATION; CORTICOSTEROID THERAPY; CORTICOTROPIN TEST; HUMAN; MALE; QUADRIPLEGIA; SEPSIS; TREATMENT OUTCOME;

EID: 0034088460     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1053/apmr.2000.3875     Document Type: Article

References (34)

1. Claus-Walker J, Halstead LS. Metabolic and endocrine changes in spinal cord injury: III. Less quanta of sensory input plus bedrest and illness. Arch Phys Med Rehabil 1982;63:628-31.
2. Wang YH, Huang TS, Lien IN. Hormone changes in men with spinal cord injuries. Am J Phys Med Rehabil 1992;71:328-32.
3. Claus-Walker J, Vallbona C, Carter RE, Lipscomb HS. Resting and stimulated endocrine function in human subjects with cervical spinal cord transection. J Chron Dis 1971;24:193-207.
4. Claus-Walker J, Halstead LS. Metabolic and endocrine changes in spinal cord injury: II (section 2). Partial decentralization of the autonomic nervous system. Arch Phys Med Rehabil 1982;63: 576-80.
5. Williams GH, Dluhy RG. Diseases of the adrenal cortex. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, editors. Harrison's principles of internal medicine. 13th ed. New York: McGraw-Hill; 1994. p. 1953-76.
6. Grant JMF, Yeo JD. Studies on the levels of 17-hydroxycorticoids in 24-hour specimens of urine from five quadriplegic patients and two paraplegic patients admitted to the Royal North Shore Hospital, Sydney. Paraplegia 1968;6:29-31.
7. Huang TS, Wang YH, Lee SH, Lai JS. Impaired hypothalamus-pituitary-adrenal axis in men with spinal cord injuries. Am J Phys Med Rehabil 1998;77:108-12.
8. Nicholas JJ, Streeten DHP, Jivoff L. Study of pituitary and adrenal function in patients with traumatic injuries of spinal cord. J Chron Dis 1969;22:463-71.
9. Culpepper-Morgan JA, Twist DJ, Petrillo CR, Soda KM, Kreek MJ. Beta-endorphin and cortisol abnormalities in spinal cordinjured individuals. Metab Clin Exp 1992;41:578-81.
10. Semenkovich CF. Endocrine diseases. In: Woodley MC, Whelan AJ, editors. Manual of medical therapeutics. Boston: Little, Brown; 1992. p. 400-18.
11. Poole CJM, Williams TDM, Lightman SL, Frankel HL. Neuroendocrine control of vasopressin secretion and its effect on blood pressure in subjects with spinal cord transection. Brain 1987;110: 727-35.
12. Szollar SM, Dunn KL, Brandt S, Fincher J. Nocturnal polyuria and antidiuretic hormone levels in spinal cord injury. Arch Phys Med Rehabil 1997;78:455-8.
13. Cheville AL, Kirshblum SC. Thyroid hormone changes in chronic spinal cord injury. J Spinal Cord Med 1995;18:227-32.
14. Huang TS, Wang YH, Lai JS, Chang CC, Lien IN. The hypothalamus-pituitary-ovary and hypothalamus-pituitary-thyroid axes in spinal cord-injured women. Metab Clin Exp 1996;45:718-22.
15. Claus-Walker J, Halstead LS. Metabolic and endocrine changes in spinal cord injury: I. The nervous system before and after transection of the spinal cord. Arch Phys Med Rehabil 1981;62:595-601.
16. Palmer JB. Depression and adrenocortical function in spinal cord injury patients: a review. Arch Phys Med Rehabil 1985;66:253-6.
17. Al-Damluji S. Adrenergic mechanisms in the control of corticotrophin secretion. J Endocrinol 1988;119:5-14.
18. Edwards AV, Jones CT. Autonomic control of adrenal function. J Anat 1993;183:291-307.
19. Ehrhart-Bornstein M, Bornstein SR, Gonzalez-Hernandez J, Holst JJ, Waterman MR, Scherbaum WA. Sympathoadrenal regulation of adrenocortical steroidogenesis. Endocrinol Res 1995;21:13-24.
20. Edwards AV, Jones CT, Bloom SR. Reduced adrenal cortical sensitivity to ACTH in lambs with cut splanchnic nerves. J Endocrinol 1986;110:81-5.
21. Engeland WC. Functional innervation of the adrenal cortex by the splanchnic nerve. Horm Metab Res 1998;30:311-4.
22. Ehrhart-Bornstein M, Bornstein SR, Scherbaum WA, Pfeiffer EF, Holst JJ. Role of vasoactive intestinal peptide in a neuroendocrine regulation of the adrenal cortex. Neuroendocrinology 1991;54: 623-8.
23. Ottenweller JE, Meier AH. Adrenal innervation may be an extrapituitary mechanism able to regulate adrenocortical rhythmicity in rats. Endocrinology 1982;111:1334-8.
24. Claus-Walker JL, Carter RE, Lipscomb HS, Vallbona C. Analysis of daily rhythms of adrenal function in men with quadriplegia due to spinal cord section. Paraplegia 1968;6:195-207.
25. Span LF, Hermus AR, Bartelink AK, Hoitsma AJ, Gimbrere JS, Smals AG, et al. Adrenocortical function: an indicator of severity of disease and survival in chronic critically ill patients. Intensive Care Med 1992;18:93-6.
26. Tsatsoulis A, Shalet SM, Harrison J, Ratcliffe WA, Beardwell CG, Robinson EL. Adrenocorticotropin deficiency undetected by standard dynamic test of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol 1988;28:225-32.
27. Wheeler G, Cumming D, Burnham R, Maclean I, Sloley BD, Bhambhani Y, et al. Testosterone, cortisol and catecholamine responses to exercise stress and autonomic dysreflexia in elite quadriplegic athletes. Paraplegia 1994;32:292-9.
28. Wheeler GD, Ashley EA, Harber V, Laskin JJ, Olenik LM, Sloley D, et al. Hormonal responses to graded-resistance, FES-assisted strength training in spinal cord-injured. Spinal Cord 1996;34: 264-7.
29. Ozcan O, Ulus IH, Yurtkuran M, Karakaya M. Release of vasopressin. cortisol and B-endorphin in tetraplegic subjects in response to head-up tilt. Paraplegia 1991;29:120-4.
30. Tchekmedyian S, Tait N, Moody M, Aisner J. High-dose megestrol acetate: a possible treatment for cachexia. JAMA 1987;257: 1195-8.
31. Oster MH, Enders SR, Samuels SJ, Cone LA, Hooton TM, Browder HP, et al. Megestrol acetate in patients with AIDS and cachexia. Ann Intern Med 1994;121:400-8.
32. Loprinzi CL, Jensen MD, Jiang NS, Schaid DJ. Effect of megestrol acetate on the human pituitary-adrenal axis. Mayo Clinic Proc 1992;67:1160-2.
33. Leinung MC, Liporace R, Miller CH. Induction of adrenal suppression by megestrol acetate in patients with AIDS. Ann Intern Med 1995;122:843-5.
34. Mann M, Koller E, Murgo A, Malozowski S, Bacsanyi J, Leinung M. Glucocorticoid-like activity of megestrol: a summary of food and drug administration experience and a review of the literature. Arch Intern Med 1997;157:1651-6.